Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (8)
  • 2025 (42)
  • 2024 (43)
  • 2023 (76)
  • 2022 (77)
  • 2021 (44)
  • 2020 (8)
  • 2019 (2)
  • 2017 (1)
  • 2016 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (253)
  • Public and Media Affairs - also see Congressional Affairs (51)

Drug Name

  • Opioids (45)
  • Fentanyl (43)
  • Oxycodone (39)
  • Hydromorphone (16)
  • Methamphetamine (12)
  • Synthetic Opioids (12)
  • Benzodiazepines (9)
  • Morphine (7)
  • Cocaine (5)
  • Amphetamines (4)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (42)
  • New England (35)
  • Headquarters (27)
  • New York (26)
  • Seattle (25)
  • Chicago (18)
  • New Jersey (17)
  • Houston (16)
  • Atlanta (13)
  • El Paso (11)
  • Miami (11)
  • New Orleans (11)
  • Omaha (8)
  • San Francisco (8)
  • St. Louis (7)
  • Rocky Mountain (6)
  • Dallas (5)
  • Phoenix (4)
  • Los Angeles (3)
  • San Diego (3)
  • Detroit (2)
  • Louisville (2)
  • Caribbean (1)
  • Philadelphia (1)
Clear All Results
302 Results - Showing 41 to 50
PRESS RELEASE

DEA Seizes Record-Breaking 2.7 Million Fentanyl Pills

U.S. Attorney General Pam Bondi joined DEA Leadership, and the men and women of the DEA El Paso Field Division, on Tuesday, May 6, 2025 to announce the single largest seizure of fentanyl pills in DEA history. During an enforcement operation the last week of April, agents from the DEA...
PRESS RELEASE

Central Coast Woman Pleads Guilty to Misusing Doctors’ Credentials to Create Bogus Medical Documents for Immigration Applicants

LOS ANGELES – A San Luis Obispo County woman who operated a medical clinic pleaded guilty today to misusing physicians’ medical identities to create hundreds of fraudulent immigration documents to help immigrants obtain lawful status in the United States and for using a deceased doctor’s credentials to acquire and distributed...
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
PRESS RELEASE

Ibrar A. Mian Named Special Agent in Charge of the DEA Washington Division

Washington, DC – In January 2025, Ibrar A. Mian was appointed as the Special Agent in Charge (SAC) of the Drug Enforcement Administration’s (DEA) Washington Division, which covers the District of Columbia, Maryland, and Virginia (DMV). Special Agent in Charge Mian's vast experience in both domestic and international drug investigations...
PRESS RELEASE

Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

CHARLOTTE, N.C. – Prescriptions Plus, a pharmacy in Gastonia, N.C., has agreed to pay $204,000 to resolve allegations that it violated the recordkeeping requirements of the Controlled Substances Act, announced Acting U.S. Attorney Lawrence J. Cameron. The Controlled Substances Act was enacted to combat illegal distribution and abuse of controlled...
PRESS RELEASE

Florence Doctor Sentenced for Distributing Oxycodone in “Sex for Scripts” Scheme

FLORENCE, S.C.— David Carlos Rodriguez, Jr., 50, of Florence, was sentenced to nearly five years in federal prison after pleading guilty to distributing Oxycodone outside the scope of medical practice and without a legitimate medical purpose. Evidence presented to the court showed that Rodriguez provided 15 prescriptions for Oxycodone over...
PRESS RELEASE

New Haven Psychiatrist to Pay More Than $450K to Settle False Claims Act and Controlled Substances Act Allegations

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Roberto Coviello, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of the Inspector General, Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England...
PRESS RELEASE

Career Special Agent Derek S. Maltz Appointed to Lead U.S. Drug Enforcement Administration

WASHINGTON – The Trump Administration has announced the appointment of Derek S. Maltz as Acting Administrator of the U.S. Drug Enforcement Administration. Maltz replaces Anne Milgram who departed the agency last week. Maltz is a passionate, dedicated, career special agent who served 28 years at DEA before retiring in 2014...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...

Pagination

  • First page «
  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster